摘要
认为医药行业的制度缺陷产生了医院同患者和药品供应商之间的信息不对称,这使得医院和医生成为了患者和药品供应商的"代理人",并且医院和医生具有操纵药品供求的"双向垄断"权力,因此,在"以药养医"的制度前提下导致了"代理人"的道德风险问题。解决该问题的办法就是建立医药市场的信号显示机制和代理人的有效监督机制。
The disadvantage of medical system in China led to the asymmetric information between hospitals, medicine providers and patients. In that case, hospitals become the deputy of medicine providers and patients, and have an impact on the medicine market. When hospitals control the demand and supply information on the medicine market and become the monopoly, the moral hazard problem emerges, some hospitals raised by medicine. We propose to establish signal guide system and deputy supervision mechanism
出处
《中国卫生经济》
2008年第6期71-73,共3页
Chinese Health Economics
关键词
药价虚高
信息不对称
代理人
道德风险
high price of medicine, asymmetric information, deputy, moral hazard
